- Half Year 2024 Idorsia Ltd Earnings Call TranscriptJul 25, 2024CHF2.74 (+18.17%)Earnings
- Idorsia Ltd to Discuss the TRYVIO FDA Approval TranscriptMar 20, 2024
- Idorsia Ltd at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 Idorsia Ltd Earnings Call TranscriptOct 24, 2023CHF1.62 (-13.10%)Earnings
- Half Year 2023 Idorsia Ltd Earnings Call TranscriptJul 25, 2023CHF6.43 (-5.72%)Earnings
- Sosei Group Corp to Acquire Idorsia Ltd Pharmaceuticals Business in Japan and APAC TranscriptJul 20, 2023
- Q1 2023 Idorsia Ltd Earnings Call TranscriptApr 25, 2023CHF8.99 (-6.98%)Earnings
- Full Year 2022 Idorsia Ltd Earnings Call TranscriptFeb 07, 2023CHF12.51 (-8.89%)Earnings
- Idorsia Ltd at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Idorsia Ltd Cenerimod Phase 3 Initiation Webcast TranscriptDec 15, 2022
- Idorsia Ltd Conference Call TranscriptNov 08, 2022
- Q3 2022 Idorsia Ltd Earnings Call TranscriptOct 25, 2022CHF13.95 (+3.95%)Earnings
- Half Year 2022 Idorsia Ltd Earnings Call TranscriptJul 26, 2022CHF11.42 (+0.62%)Earnings
- Idorsia Ltd To Discuss PRECISION top-line results TranscriptMay 24, 2022
- Full Year 2021 Idorsia Ltd Earnings Call TranscriptFeb 08, 2022CHF19.88 (-4.70%)Earnings
- Idorsia Ltd To Discuss Daridorexant Phase 3 program published in The Lancet Neurology Call TranscriptJan 20, 2022
- Idorsia Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Half Year 2021 Idorsia Ltd Earnings Call TranscriptJul 27, 2021CHF24.6 (-1.99%)Earnings
- Idorsia Ltd To Discuss Phase 3 Program -Corporate Call TranscriptJun 28, 2021
- Idorsia Ltd - Pre Recorded Special Call TranscriptMar 10, 2021
- Full Year 2020 Idorsia Ltd Earnings Call TranscriptFeb 04, 2021CHF26.68 (-1.11%)Earnings
- Idorsia Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Half Year 2020 Idorsia Ltd Earnings Call TranscriptJul 23, 2020CHF26.6 (+0.23%)Earnings
- Idorsia Ltd - Special Call TranscriptJul 06, 2020
- Idorsia Ltd - Special Call TranscriptApr 20, 2020
- Full Year 2019 Idorsia Ltd Earnings Call TranscriptFeb 06, 2020CHF32.23 (-1.26%)Earnings
- Half Year 2019 Idorsia Ltd Earnings Call TranscriptJul 23, 2019CHF21.39 (-7.52%)Earnings
Idorsia Ltd To Discuss Daridorexant Phase 3 program published in The Lancet Neurology Call Transcript
Good day and thank you for standing by. Welcome to the daridorexant Phase III program published in The Lancet Neurology Conference Call. (Operator Instructions)
I must advise you that this conference call is being recorded today, Thursday, the 20th of January 2022. I would now like to hand over to your speaker for today, Mr. Andrew Weiss. Please go ahead, sir.
Thank you, operator. Good morning, good afternoon, everyone. This is Andrew speaking, Investor Relations at Idorsia. We're here to have a webcast to discuss the newly published results of daridorexant in the Lancet Neurology publication that was made available this morning.
With me on the call today are our CEO, Jean-Paul Clozel; our Chief Scientific Officer, Martine Clozel; our Head of Global Clinical Development, Guy Braunstein. And joining us afterwards for the Q&A, we will also have Simon Jose. Next slide.
As customary, we will be making forward-looking statements during this webcast
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)